Navigation Links
Survivors of Rare Ovarian Cancer may Retain Menstrual Function and Reproductive Ability

A new prospective study suggests that ovarian germ cell tumour patients treated with platinum-based chemotherapy and fertility-sparing surgery may retain their menstrual function and reproductive ability.

The study, published in the Journal of Clinical Oncology, also found that despite having reproductive and sexual concerns, survivors were more likely than their healthy counterparts to be involved in meaningful, positive relationships.

Researchers at The University of Texas M. D. Anderson Cancer Center and the Gynecologic Oncology Group claim that this is the largest and most comprehensive survey of survivors ever conducted.

Lead author of the study, Dr. David Gershenson, says that germ cell tumours, a disease in which malignant cells form in the germ or egg of the ovary, constitute just five percent of all ovarian cancers diagnosed.

He explains that there has been a tremendous amount of interest in fertility because it relates to germ cell tumour survivors. Ovarian germ cell tumours often occur in girls and young women, with the average age of diagnosis occurring in the teenage years.

"Before the 1970s, there was no effective treatment for ovarian germ cell tumour patients and the death rate was extremely high. However, with the introduction of platinum-based combination chemotherapy, there's been a dramatic increase in survival, with cure rates now reaching close to 100 percent.

Simultaneously in the 1970s, gynaecologic oncologists began to realize that fertility-sparing surgery could be performed safely and without compromising a woman's curability," says Dr. Gershenson.

During the study, the researchers surveyed 132 germ cell tumour survivors formally enrolled in M. D. Anderson or Gynecologic Oncology Group clinical trials all over the nation. Each patient received platinum-based combination chemotherapy following surgery. The women were compared to 137 health y women, all acquaintances of the survivors. Both the survivors and the acquaintances filled out questionnaires, and were matched for age, race, and education.

Seventy-one of the 132 survivors had fertility-sparing surgery as part of their treatment. The researchers noted that of the 71 patients who had fertility-sparing surgery, 62 women (87 per cent) were still having menstrual periods and 24 survivors had given birth to 37 babies.

"At the time of the study, the median survivor's age was just 35.5 years - this is a very young cohort of survivors. One can only assume that the women will have, or likely already have had, more children since the study," says Dr. Gershenson.

It was also observed that as compared to the healthy women, germ cell tumour survivors had significantly greater reproductive concerns and experienced less sexual pleasure and more sexual discomfort, although the survivors were more likely to be in partnered, meaningful relationships.

"The finding should allow oncologists and therapists to better inform and counsel patients and their families about expectations in the perioperative period, during primary treatment and long term. Ultimately as a cancer community, we need to develop better interventions and pay much more attention to both the psycho-social and fertility issues of our patients," says Dr. Gershenson.

He also stressed the importance of having fertility-sparing surgery performed by a board-certified gynaecological oncologist who understands the clinical behaviour of ovarian germ cell tumours, and who is trained to optimise patients' probability of undergoing appropriate surgery and chemotherapy.

"Still in 2007, despite medical advances, too many of these patients are operated on by general obstetricians and gynaecologists or general surgeons who do not make a proper diagnosis during surgery, or may not truly understand the biology of this disease. As a r esult, both ovaries and the uterus are removed, leaving a patient unnecessarily sterile," he said.


'"/>




Related medicine news :

1. Breast Cancer Survivors Worry About Infertility
2. Breast Cancer Survivors Worry About Infertility
3. An Incentive For Breast Cancer Survivors
4. Better Care Required for Breast Cancer Survivors
5. Exercising Good For Stroke Survivors
6. Tsunami Survivors Face Pneumonia Threat
7. Survivors of childhood cancer may have long-term health problems
8. Encephalitis Survivors Face The Risk Of Becoming Disabled
9. Socialization A Serious Trouble For Childhood Cancer Survivors
10. Pakistani Quake Survivors Face Outbreak Of Diarrhea
11. Chronic Post-Traumatic Stress Disorder (PTSD) Risk In Young Natural Disaster Survivors
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/26/2017)... ... February 26, 2017 , ... ... technology standard in staffing, scheduling, and reporting for healthcare organizations. This comprehensive ... throughout the entire staffing process. StaffBridge technology improves staffing efficiency, maximizes resource ...
(Date:2/25/2017)... Viejo, CA (PRWEB) , ... February 25, 2017 , ... ... with ProSharpen Color tools from Pixel Film Studios. With ProSharpen Color users have total ... sliders to easily refine their color range. With color spectrum tools users can visually ...
(Date:2/24/2017)... Princeton, NJ (PRWEB) , ... February 24, 2017 ... ... organization that provides business development, education, networking and recognition opportunities as well as ... at Bell Works in Holmdel, NJ on February 23. The Council's Innovation ...
(Date:2/24/2017)... ... February 24, 2017 , ... In the Health Care IT campaign, ... priority because it’s not if you will be attacked, but when.” However, he and ... to digital health care. , Improvements in auditing and monitoring have taken security in ...
(Date:2/24/2017)... , ... February 24, 2017 , ... With ProGlass Prism ... Pro X . Users have total control over position, rotation, distortion, edge softness, edge ... within Final Cut Pro X. , With ProGlass Prism users are given the tools ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... LG Innotek hat heute die weltweit erste ... das 1,5-fache des 45-mW-Moduls der Konkurrenz. UV-C ... und 280 nm und eignet sich damit für Sterilisationsaufgaben. Es ... zerstört. Das Produkt von LG Innotek erzeugt UV-Strahlung im ... ...
(Date:2/23/2017)... Februar 2017 Im Rahmen seiner Schlüsselwachstumsstrategie ... in der südwestlichen chinesischen Provinz Guizhou, 2017 mit dem Angebot ... aktiv an der Entwicklung einer eingebetteten Hightech-Schlüsselindustrie. Foto ... Reading ... ...
(Date:2/23/2017)... 23, 2017 Obese people are ... for varicose veins in their body. The rising number ... the adoption of endovenous laser therapy for treatment of ... laser therapy market, published by Future Market Insights, ... and consequences of obesity have collectively factored the growth ...
Breaking Medicine Technology: